TY - JOUR
T1 - Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi
AU - Pirttimaa, Minni
AU - Nasereddin, Abedelmajeed
AU - Kopelyanskiy, Dmitry
AU - Kaiser, Marcel
AU - Yli-Kauhaluoma, Jari
AU - Oksman-Caldentey, Kirsi-Marja
AU - Brun, Reto
AU - Jaffe, Charles L.
AU - Moreira, Vânia M.
AU - Alakurtti, Sami
PY - 2016
Y1 - 2016
N2 - Dehydroabietylamine (1) was used as a starting material
to synthesize a small library of dehydroabietyl amides by
simple and facile methods, and their activities against
two disease-causing trypanosomatids, namely, Leishmania
donovani and Trypanosoma cruzi, were assayed. The most
potent compound, 10, an amide of dehydroabietylamine and
acrylic acid, was found to be highly potent against these
parasites, displaying an IC50 value of 0.37 µM against L.
donovani axenic amastigotes and an outstanding
selectivity index of 63. Moreover, compound 10 fully
inhibited the growth of intracellular amastigotes in
Leishmania donovani-infected human macrophages with a low
IC50 value of 0.06 µM. This compound was also highly
effective against T. cruzi amastigotes residing in L6
cells with an IC50 value of 0.6 µM and high selectivity
index of 58, being 3.5 times more potent than the
reference compound benznidazole. The potent activity of
this compound and its relatively low cytotoxicity make it
attractive for further development in pursuit of better
drugs for patients suffering from leishmaniasis and
Chagas disease.
AB - Dehydroabietylamine (1) was used as a starting material
to synthesize a small library of dehydroabietyl amides by
simple and facile methods, and their activities against
two disease-causing trypanosomatids, namely, Leishmania
donovani and Trypanosoma cruzi, were assayed. The most
potent compound, 10, an amide of dehydroabietylamine and
acrylic acid, was found to be highly potent against these
parasites, displaying an IC50 value of 0.37 µM against L.
donovani axenic amastigotes and an outstanding
selectivity index of 63. Moreover, compound 10 fully
inhibited the growth of intracellular amastigotes in
Leishmania donovani-infected human macrophages with a low
IC50 value of 0.06 µM. This compound was also highly
effective against T. cruzi amastigotes residing in L6
cells with an IC50 value of 0.6 µM and high selectivity
index of 58, being 3.5 times more potent than the
reference compound benznidazole. The potent activity of
this compound and its relatively low cytotoxicity make it
attractive for further development in pursuit of better
drugs for patients suffering from leishmaniasis and
Chagas disease.
U2 - 10.1021/acs.jnatprod.5b00990
DO - 10.1021/acs.jnatprod.5b00990
M3 - Article
SN - 1520-6025
VL - 79
SP - 362
EP - 368
JO - Journal of Natural Products
JF - Journal of Natural Products
IS - 2
ER -